María Victoria
Mateos Manteca
Profesora Titular de Universidad
Centre hospitalier Lyon Sud
Pierre-Bénite, FranciaPublikationen in Zusammenarbeit mit Forschern von Centre hospitalier Lyon Sud (6)
2024
-
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 2, pp. 696-715
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593
2023
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458
2016
-
Multiple myeloma: patient outcomes in real-world practice
British Journal of Haematology, Vol. 175, Núm. 2, pp. 252-264
-
Multiple myeloma: practice patterns across Europe
British Journal of Haematology, Vol. 175, Núm. 1, pp. 66-76